The FDA approved vorasidenib earlier this month for adult and pediatric patients 12 and older with Grade2 astrocytoma or oligodendroglioma.
Source: WRAL News
FDA gives patients hope after approving brain cancer drug with Duke ties
Published in Marshallberg
Be First to Comment